PLIANT THERAPEUTICS INC. - COMMON STOCK

Pliant Therapeutics Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis

07 9 2021 07:00:01 提供 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Webcast to Present Interim Clinical Data from Ongoing Phase 2a PET Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis

03 9 2021 16:10:00 提供 Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results

09 8 2021 16:05:02 提供 Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in the BTIG Biotechnology Conference

03 8 2021 08:00:01 提供 Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

10 5 2021 16:21:16 提供 Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

05 5 2021 08:05:00 提供 Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference

05 4 2021 08:00:00 提供 Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

16 3 2021 16:05:00 提供 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner

16 3 2021 08:00:01 提供 Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Upcoming Virtual Investor Events

18 2 2021 08:30:00 提供 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

12 1 2021 08:00:01 提供 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF

04 1 2021 08:00:01 提供 Nasdaq GlobeNewswire